| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |